{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:37:49Z","timestamp":1785343069086,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-002"],"award-info":[{"award-number":["2021-I2M-1-002"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-029"],"award-info":[{"award-number":["2021-I2M-1-029"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2022-I2M-1-020"],"award-info":[{"award-number":["2022-I2M-1-020"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-030"],"award-info":[{"award-number":["2021-I2M-1-030"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600546"],"award-info":[{"award-number":["81600546"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.biopha.2024.117223","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T21:04:53Z","timestamp":1722459893000},"page":"117223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Identification of a novel xanthine oxidoreductase inhibitor for hyperuricemia treatment with high efficacy and safety profile"],"prefix":"10.1016","volume":"178","author":[{"given":"Xuechen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chufan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baolian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2024.117223_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","article-title":"Gout","volume":"5","author":"Dalbeth","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.biopha.2024.117223_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/13813455.2014.924145","article-title":"Serum uric acid levels and metabolic syndrome","volume":"120","author":"Ciarla","year":"2014","journal-title":"Arch. Physiol. Biochem"},{"issue":"17","key":"10.1016\/j.biopha.2024.117223_bib3","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"Feig","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.biopha.2024.117223_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/j.ajkd.2012.07.021","article-title":"Uric acid as a target of therapy in CKD","volume":"61","author":"Jalal","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.biopha.2024.117223_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijcard.2021.11.076","article-title":"Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease","volume":"349","author":"Konishi","year":"2022","journal-title":"Int. J. Cardiol."},{"issue":"11","key":"10.1016\/j.biopha.2024.117223_bib6","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1253\/circj.CJ-17-0438","article-title":"Cross-Over trial of febuxostat and topiroxostat for hyperuricemia with cardiovascular disease (TROFEO trial)","volume":"81","author":"Sezai","year":"2017","journal-title":"Circ. J."},{"issue":"5","key":"10.1016\/j.biopha.2024.117223_bib7","doi-asserted-by":"crossref","first-page":"E827","DOI":"10.1152\/ajpendo.00378.2020","article-title":"New insights into purine metabolism in metabolic diseases: role of xanthine oxidoreductase activity","volume":"319","author":"Furuhashi","year":"2020","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.biopha.2024.117223_bib8","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.bbadis.2014.05.022","article-title":"Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme","volume":"1842","author":"Battelli","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2024.117223_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101882","article-title":"Xanthine oxidoreductase: one enzyme for multiple physiological tasks","volume":"41","author":"Bortolotti","year":"2021","journal-title":"Redox Biol."},{"issue":"6","key":"10.1016\/j.biopha.2024.117223_bib10","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1172\/JCI112990","article-title":"Conversion of xanthine dehydrogenase to oxidase in ischemic rat tissues","volume":"79","author":"Engerson","year":"1987","journal-title":"J. Clin. Invest."},{"issue":"5 Pt 1","key":"10.1016\/j.biopha.2024.117223_bib11","first-page":"G768","article-title":"Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation","volume":"254","author":"Parks","year":"1988","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2024.117223_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/01616412.1992.11740077","article-title":"Change of xanthine dehydrogenase and xanthine oxidase activities in rat brain following complete ischaemia","volume":"14","author":"Oka","year":"1992","journal-title":"Neurol. Res"},{"key":"10.1016\/j.biopha.2024.117223_bib13","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.12659\/MSM.899852","article-title":"Hyperuricemia-Related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview","volume":"22","author":"Chen","year":"2016","journal-title":"Med Sci. Monit."},{"issue":"6 Suppl","key":"10.1016\/j.biopha.2024.117223_bib14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/annrheumd00512-0010","article-title":"Enzymatic and metabolic studies with allopurinol","volume":"25","author":"Elion","year":"1966","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.biopha.2024.117223_bib15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s40264-013-0084-0","article-title":"Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012","volume":"36","author":"Ramasamy","year":"2013","journal-title":"Drug Saf."},{"issue":"9","key":"10.1016\/j.biopha.2024.117223_bib16","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3899\/jrheum.110092","article-title":"Safety and efficacy of febuxostat treatment in subjects with gout and severe allopurinol adverse reactions","volume":"38","author":"Chohan","year":"2011","journal-title":"J. Rheuma"},{"issue":"3","key":"10.1016\/j.biopha.2024.117223_bib17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3899\/jrheum.111161","article-title":"Febuxostat hypersensitivity","volume":"39","author":"Abeles","year":"2012","journal-title":"J. Rheuma"},{"issue":"13","key":"10.1016\/j.biopha.2024.117223_bib18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa1710895","article-title":"Cardiovascular safety of febuxostat or allopurinol in patients with gout","volume":"378","author":"White","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"10264","key":"10.1016\/j.biopha.2024.117223_bib19","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/S0140-6736(20)32234-0","article-title":"Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a\u00a0multicentre, prospective, randomised, open-label, non-inferiority trial","volume":"396","author":"Mackenzie","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biopha.2024.117223_bib20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s10157-014-0935-8","article-title":"Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout","volume":"18","author":"Hosoya","year":"2014","journal-title":"Clin. Exp. Nephrol."},{"issue":"11","key":"10.1016\/j.biopha.2024.117223_bib21","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1253\/circj.CJ-17-0438","article-title":"Cross-Over trial of febuxostat and topiroxostat for hyperuricemia with cardiovascular disease (TROFEO trial)","volume":"81","author":"Sezai","year":"2017","journal-title":"Circ. J."},{"key":"10.1016\/j.biopha.2024.117223_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106162","article-title":"Discovery of novel 1,2,4-triazole derivatives as xanthine oxidoreductase inhibitors with hypouricemic effects","volume":"129","author":"Yang","year":"2022","journal-title":"Bioorg. Chem."},{"issue":"33","key":"10.1016\/j.biopha.2024.117223_bib23","first-page":"218","article-title":"Establishment of a screening system for xanthine oxidase (XOD) inhibitors","volume":"2","author":"Zhenxin Yan","year":"2019","journal-title":"Chin. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.biopha.2024.117223_bib24","first-page":"756","article-title":"Urate transporter URAT1 in hyperuricemia: new insights from hyperuricemic models","volume":"49","author":"Li","year":"2019","journal-title":"Ann. Clin. Lab Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.117223_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/aps.2015.143","article-title":"Investigation of miscellaneous hERG inhibition in large diverse compound collection using automated patch-clamp assay","volume":"37","author":"Yu","year":"2016","journal-title":"Acta Pharm. Sin."},{"issue":"1","key":"10.1016\/j.biopha.2024.117223_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharm. Rev."},{"issue":"2-3","key":"10.1016\/j.biopha.2024.117223_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0014-2999(93)90201-R","article-title":"Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents","volume":"241","author":"Osada","year":"1993","journal-title":"Eur. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2024.117223_bib28","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1074\/jbc.M208307200","article-title":"An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition","volume":"278","author":"Okamoto","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.biopha.2024.117223_bib29","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1073\/pnas.0400973101","article-title":"The crystal structure of xanthine oxidoreductase during catalysis: Implications for reaction mechanism and enzyme inhibition","volume":"101","author":"Okamoto","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.biopha.2024.117223_bib30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF02549601","article-title":"Xanthine urolithiasis: ultrastructure analysis of renal and bladder calculi","volume":"23","author":"Kario","year":"1991","journal-title":"Int. Urol. Nephrol."},{"issue":"2","key":"10.1016\/j.biopha.2024.117223_bib31","first-page":"328","article-title":"Xanthine urolithiasis","volume":"21","author":"Gargah","year":"2010","journal-title":"Saudi J. Kidney Dis. Transpl."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224011077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224011077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:20:21Z","timestamp":1777861221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224011077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":31,"alternative-id":["S0753332224011077"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117223","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a novel xanthine oxidoreductase inhibitor for hyperuricemia treatment with high efficacy and safety profile","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117223"}}